Bicycle Therapeutics Limited BCYC 深 滬
已收盤 12-12 16:00:00 美东时间
7.45
+0.020
+0.27%
華盛通- 最 高7.55
- 今 開7.44
- 成交量 15.64万股
- 最 低 7.30
- 昨 收 7.43
- 總市值 5.16亿
- 52周最高 15.47
- 市盈率 靜 --
- 換手率 0.23%
- 52周最低 6.03
- 委 比 -5.44%
- 總股本 6930.65万
- 歷史最高 62.075
- 量 比 0.64
- 振 幅 3.36%
- 歷史最低 6.03
- 每 手 1
- 風險率 2.62%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 摩根大通上调百度至"超配"，目标价升至188美元！Navan获多家机构首予"买入"评级，目标价最高30美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从4美元升至9美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从32美元升至38美元
11-25 10:27
Truist Securities Initiates Coverage On Bicycle Therapeutics with Hold Rating, Announces Price Target of $10
Truist Securities analyst Gregory Renza initiates coverage on Bicycle Therapeutics (NASDAQ:BCYC) with a Hold rating and announces Price Target of $10.
11-25 01:54
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
11-03 20:20
RBC Capital Downgrades Bicycle Therapeutics to Sector Perform, Lowers Price Target to $11
RBC Capital analyst Leonid Timashev downgrades Bicycle Therapeutics (NASDAQ:BCYC) from Outperform to Sector Perform and lowers the price target from $27 to $11.
10-31 17:51
Bicycle Therapeutics Q3 EPS $(0.85) Beats $(1.09) Estimate, Sales $11.734M Beat $7.333M Estimate
Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(1.09) by 22.37 percent. This is a 14.86 percent decrease over losses of $(0.74) per share
10-30 19:44
Bicycle Therapeutics Expands Board with New Appointments
Bicycle Therapeutics ( ($BCYC) ) has provided an announcement. On September 8, ...
09-09 04:40
4 Analysts Assess Bicycle Therapeutics: What You Need To Know
In the last three months, 4 analysts have published ratings on Bicycle Therapeu...
08-13 03:00
Oppenheimer Maintains Outperform on Bicycle Therapeutics, Lowers Price Target to $44
Oppenheimer analyst Jay Olson maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Outperform and lowers the price target from $48 to $44.
08-11 21:06
